[HTML][HTML] miR-200c dampens cancer cell migration via regulation of protein kinase A subunits

FC Sigloch, UC Burk, ML Biniossek, T Brabletz… - Oncotarget, 2015 - ncbi.nlm.nih.gov
FC Sigloch, UC Burk, ML Biniossek, T Brabletz, O Schilling
Oncotarget, 2015ncbi.nlm.nih.gov
Expression of miR-200c is a molecular switch to determine cellular fate towards a
mesenchymal or epithelial phenotype. miR-200c suppresses the early steps of tumor
progression by preventing epithelial-mesenchymal transition (EMT) and intravasation of
tumor cells. Unraveling the underlying molecular mechanisms might pinpoint to novel
therapeutic options. To better understand these mechanisms it is crucial to identify targets of
miR-200c. Here, we employ a combination of quantitative proteomic and bioinformatic …
Abstract
Expression of miR-200c is a molecular switch to determine cellular fate towards a mesenchymal or epithelial phenotype. miR-200c suppresses the early steps of tumor progression by preventing epithelial-mesenchymal transition (EMT) and intravasation of tumor cells. Unraveling the underlying molecular mechanisms might pinpoint to novel therapeutic options. To better understand these mechanisms it is crucial to identify targets of miR-200c. Here, we employ a combination of quantitative proteomic and bioinformatic strategies to identify novel miR-200c targets. We identify and confirm two subunits of the central cellular kinase protein kinase A (PKA), namely PRKAR1A and PRKACB, to be directly regulated by miR-200c. Notably, siRNA-mediated downregulation of both proteins phenocopies the migratory behavior of breast cancer cells after miR-200c overexpression. Patient data from publicly accessible databases supports a miR-200c-PKA axis. Thus, our study identifies the PKA heteroprotein as an important mediator of miR-200c induced repression of migration in breast cancer cells. By bioinformatics, we define a miRNA target cluster consisting of PRKAR1A, PRKAR2B, PRKACB, and COF2, which is targeted by a group of 14 miRNAs.
ncbi.nlm.nih.gov